Keywords: qlt, 6-month, eligard, cleared, eu, canadian, drugmaker

QLT's 6-month Eligard cleared in EU

Article | 10 September 2007

Print This

Canadian drugmaker QLT's prostate cancer drug Eligard (leuprolide) has been approved in the European Union in a 45mg six-month formulation. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in